Pfizer To Buy Serenex In A Cancer Drug Move
In a move to bolster its cancer treatment drug supply Pfizer said that it has reached a deal with Serenex to buy the pharmaceutical drug company.
Serenex is NC based drug company that owns the rights to a drug that treats cancer tumors and fights cancers of the blood, lymph nodes and bone marrow. The drug, SNX-5422, is currently in phase I trials, the earliest of the three stages of human testing. Pfizer also will acquire Serenex's drug discovery technology.
On February 27,